Biogen and Teckro at SCOPE 2026: Doing the Right Thing for Patients
Delivering Individual Data Records to Participants at Scale.
We’re thrilled to announce that Teckro will share the stage with Biogen at SCOPE 2026 in Orlando! Join us for our joint session:
Doing the Right Thing: Delivering Individual Data Records to Participants at Scale
Wednesday, February 4th, 8:35 AM at SCOPE 2026.
Speakers:
- Jane Twitchen: Executive Director, Head Clinical Trial Accelerator Unit, Global Clinical Operations, Biogen.
- Brian Deighan: Program Lead, Program Management, Teckro.
Why this matters
Regulatory expectations are evolving, and patient engagement remains a central focus in clinical trials. Global regulatory bodies, and updated guidelines like ICH E6(R3), emphasize the importance of giving participants access to their clinical trial data. At the same time, patients themselves are increasingly seeking personalized study results to inform their treatment decisions.
Designing trials that deliver value and meaningful insights to patients – while supporting and engaging sites – is a complex challenge.
What you'll learn
In this session, Biogen and Teckro will explore how scalable technology can enable patient-friendly studies without compromising operational feasibility. We'll share:
• Practical tools and approaches for gathering and returning individual data records
• A repeatable framework that connects scientific intent with real-world delivery
• Insights on aligning patient engagement with site efficiency
This discussion is part of the Outsourcing Track, under the morning theme:
The Role of Innovation and Technology in Operational Excellence.
Why attend?
If you’re looking for strategies that enable you to meet regulatory expectations, empower patients, and streamline site operations, this session is for you. Together, Biogen and Teckro will show how innovation can make “doing the right thing” achievable at scale.
Let us know if you’re going to be at SCOPE - we’ll also be exhibiting at the event and our team would love to meet you.
Patient-friendly studies that stay on track
Join Biogen and Teckro at SCOPE 2026 as we discuss enabling patient data return at scale, including practical considerations for digital innovation strategies that balance evolving regulatory guidance, patient expectations, and site needs.
